Tobacco regulatory science: Research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products

Nicotine and Tobacco Research

Volumn 16, Issue 8, 2014, Pages 1045-1049

  Ashley, David L ^a   Backinger, Cathy L ^a   van Bemmel, Dana M ^a   Neveleff, Deborah J ^a  

^a CENTER FOR TOBACCO PRODUCTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; APPLIED RESEARCH; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HEALTH HAZARD; MARKETING; NOTE; PACKAGING; PRIORITY JOURNAL; PUBLIC HEALTH; SCIENCE; TOBACCO; TOBACCO INDUSTRY; COMMERCIAL PHENOMENA; GOVERNMENT REGULATION; HUMAN; LEGISLATION AND JURISPRUDENCE; RESEARCH; SMOKING; STANDARDS; UNITED STATES;

COMMERCE; GOVERNMENT REGULATION; HUMANS; MARKETING; PUBLIC HEALTH; RESEARCH; SMOKING; TOBACCO INDUSTRY; TOBACCO PRODUCTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84904322884     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu038     Document Type: Note

References (20)

1. Ashley, D. L., & Backinger, C. L. (2012). The Food and Drug Administration's regulation of tobacco: The Center for Tobacco Products' Office of Science. American Journal of Preventive Medicine, 43, S255-S263. doi:10.1016/j. amepre.2012.08.004.
2. DiFranza, J. R. (2012). Research opportunities concerning youth and the Family Smoking Prevention and Tobacco Control Act. Nicotine & Tobacco Research, 14, 54-61. doi:10.1093/ntr/ntq149.
3. Family Smoking Prevention and Tobacco Control Act. (2009). Public Law 111-31, June 22, 2009.
4. FitzGerald, G. A. (2011). Regulatory science: What it is and why we need it. Clinical Pharmacology and Therapeutics, 89, 291-294. doi:10.1038/clpt.2010.276.
5. Food and Drug Administration. (2011). Advancing regulatory science at FDA: A strategic plan. Retrieved from www.fda. gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm.
6. Goodman, J. L. (2012). Transforming regulatory science 2012: Making a difference. Clinical Pharmacology and Therapeutics, 91, 375-377. doi:10.1038/clpt.2011.329.
7. Hamburg, M. A. (2010). Shattuck lecture: Innovation, regulation, and the FDA. New England Journal of Medicine, 363, 2228-2232. doi:10.1056/NEJMsa1007467.
8. Hamburg, M. A. (2011). Advancing regulatory science. Science, 331, 987. doi:10.1016/j.yrtph.2012.02.001.
9. Hammond, D. (2012). Tobacco packaging and labeling policies under the U.S. Tobacco Control Act: Research needs and priorities. Nicotine & Tobacco Research, 14, 62-74. doi:10.1093/ntr/ntr182.
10. Hatsukami, D. K., Biener, L., Leischow, S. J., & Zeller, M. R. (2012). Tobacco and nicotine product testing. Nicotine & Tobacco Research, 14, 7-17. doi:10.1093/ntr/ntr027.
11. Hecht, S. S. (2012). Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine & Tobacco Research, 14, 18-28. doi:10.1093/ntr/ntq216.
12. Henningfield, J. E. (2011). Tobacco psychopharmacology and public health policy: It takes a community. Experimental and Clinical Psychopharmacology, 19, 249-262. doi:10.1037/a0024316.
13. Husten, C. G., & Deyton, L. R. (2013). Understanding the Tobacco Control Act: Efforts by the US Food and Drug Administration to make tobacco-related morbidity part of the USA's past, not its future. The Lancet, 381, 1570-1580. doi:10.1016/S0140-6736(13)60735-7.
14. Leischow, S. J., Zeller, M., Backinger, C. L. (2012). Research priorities and infrastructure needs of the Family Smoking Prevention and Tobacco Control Act: Science to inform FDA policy. Nicotine & Tobacco Research, 14, 1-6. doi:10.1093/ntr/ntr057.
15. Norman, B. (2012). The Food and Drug Administration gets new tools to spur regulatory science. Health Affairs (Millwood), 31, 1919-1922. doi:10.1377/hlthaff.2012.0615.
16. O'Connor, R. J. (2012). Postmarketing surveillance for "modified-risk" tobacco products. Nicotine & Tobacco Research, 14, 29-42. doi:10.1093/ntr/ntq243.
17. Patel, M., & Miller, M. A. (2012). Impact of regulatory science on global public health. Kaohsiung Journal of Medical Sciences, 28, S5-S9. doi:10.1016/j.kjms.2012.05.003.
18. Ribisl, K. M. (2012). Research gaps related to tobacco product marketing and sales in the Family Smoking Prevention and Tobacco Control Act. Nicotine & Tobacco Research, 14, 43-53. doi:10.1093/ntr/ntr098.
19. Sukkar, E. (2011). Lack of investment in regulatory science is part of "innovation gap," believes FDA commissioner. British Medical Journal, 343, 8017. doi:10.1136/bmj.d8017.
20. Uchiyama, M. (1995). Regulatory science. PDA Journal of Pharmaceutical Science and Technology, 49, 185-187. Retrieved from http://journal.pda.org/content/49/4/185.full. pdf+html.